ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IPO Ip Group Plc

47.60
0.50 (1.06%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Ip Group Plc LSE:IPO London Ordinary Share GB00B128J450 ORD 2P
  Price Change % Change Share Price Shares Traded Last Trade
  0.50 1.06% 47.60 1,751,013 16:35:05
Bid Price Offer Price High Price Low Price Open Price
47.60 47.80 47.95 46.25 47.00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services -299.8M -344.5M -0.3322 -1.43 494.09M
Last Trade Time Trade Type Trade Size Trade Price Currency
18:09:59 O 23,128 47.463 GBX

Ip (IPO) Latest News (1)

Ip (IPO) Discussions and Chat

Ip Forums and Chat

Date Time Title Posts
23/3/202410:00IP Group PLC2,919
27/9/202107:52ONT future steps.4
23/12/202009:51IP Group - commercialising university technology.971
11/10/201206:43::: The DIRECT LINE IPO :::83
08/11/201007:59IP 2 IPO, digging up value, from the boffins.213

Add a New Thread

Ip (IPO) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2024-03-28 18:10:1047.4623,12810,977.24O
2024-03-28 18:08:5147.5013,7556,533.07O
2024-03-28 18:08:2547.802,5821,234.20O
2024-03-28 17:56:2447.60136.19O
2024-03-28 17:28:2747.4310,5004,980.47O

Ip (IPO) Top Chat Posts

Top Posts
Posted at 29/3/2024 08:20 by Ip Daily Update
Ip Group Plc is listed in the Finance Services sector of the London Stock Exchange with ticker IPO. The last closing price for Ip was 47.10p.
Ip currently has 1,036,914,787 shares in issue. The market capitalisation of Ip is £494,089,896.
Ip has a price to earnings ratio (PE ratio) of -1.43.
This morning IPO shares opened at 47p
Posted at 13/3/2024 14:35 by houseofpain1
Istesso has strong potential to drive a share price recovery in the near term. Phase 2b data fairly imminent by the sound of it and likelihood is that it is positive which should drive a significant valuation uplift. Bear in mind that Hambro Perks were looking at IPO'ing this at a valuation of "several hundred million pounds" this time last year. It is currently held at £200m and represents 11.0p of NAV.

Nanopore. Share price lows are likely in now I reckon. CEO's golden share falls away at the end of this year so potential for some corporate activity after that.

Hysata obviously had a stellar year and there could be much, much more to come there.

Oxa and FeatureSpace both appear to be progressing well.

If some of this "good stuff" happens, then it will make a decent difference at the NAV level and should make a very significant difference at the share price level.
Posted at 13/3/2024 07:57 by jaf111
Can someone please explain the logic re pausing the divi….specifically to address the discount to NAV as per Chairman’s summary…..surely the reverse would be more applicable imho…..

From today’s RNS -

Addressing the discount to Net Asset Value ('NAV')

The Board set one of its objectives at the outset of 2023 to take steps designed to narrow the discount at which our shares trade, versus the stated NAV per share. We recognise that continuation of this discount is of considerable disappointment to our shareholders.

We also concluded that we should pause paying a dividend while our shares stood at a significant discount to NAV and should embark upon a modest share buyback programme, both to capture the discount and evidence whether such market intervention would meaningfully narrow the discount. We announced a buyback programme of up to £20m on 18 December 2023. To date we have bought 5,225,207 shares at an average price of 51.4p.
Posted at 13/3/2024 07:42 by pugugly
"Strong balance sheet and liquidity with gross cash of £226.9m (2022: £241.5m)

- £73.2m portfolio investment into 33 companies across our three high-growth sectors (2022: £93.5m, 46 companies) representing around 10% of capital raised by our portfolio (2022: 9% of total capital raised)

- Cash proceeds in line with expectations at £38.6m (2022 £28.1m)

- NAV per share declined to 114.8p (-13%), driven primarily by adjustments to the carrying values of First Light Fusion, our US platform, Hinge Health and Akamis Bio and reflecting a fair value decrease of listed holding Oxford Nanopore, Since year-end, further reduction in listed portfolio of £45.4m.

- Third party managed funds of £650m (2022: £700m), with more than £100m available for investment"

HOWEVER at closing share price yesterday of 52o discount still over 50% of claimed NAV but valuation of unlisted companies still a very inexact measure, but a 50% discount might allow a sufficient margin.
Thoughts??
Posted at 04/2/2024 15:18 by brucie5
p1nkfish3 Feb '24 - 18:36 - 2880 of 2884
0 0 0
Brucie, IPO will come good but the age old questions apply.
--------------------------------------------------------------

I've bought in on behalf of a charity fund that I help run; almost entirely for income generation via ITS and large financials/insurers. But I thought I'd stick in a holding of IPO, since at current levels it has an insane discount, large cash pile and a dividend that isn't too far from what the charity would get in a bank. Folio designed pretty much never to be traded; so we have a lot of patience. I'm hoping on the way for some special dividends to sweeten the shareholders' pill? What do you reckon?
Posted at 04/2/2024 10:27 by bamboo2
IPO's ONT shares at 156.8p each are currently worth approx £128,673,441.79

NAV of ONT per IPO share.
128,673,441/1,035,037,800 [IPO shares] = 12.43p
Posted at 03/2/2024 21:13 by apple53
Thanks for the updates and analysis from various posters here.
Can anyone easily estimate the NAV for ONT's share price about now? ie down a quarter from the number included in the 117p (though thankfully up 10% from the recent low)?

I wasn't following closely - I have a meaningful position but it's so depressing I don't like to focus..........
...but at IPO's low surely half the market cap was cash and with the NAV (using the 117p rather than previous higher ones, and bearing in mind ONT hadn't had its recent collapse), it was actually trading at a 75% discount. There are some heavily discounted investment trusts around but that was just crazy and I should have doubled up (I bought a lot of SSIT at a similar level). Now maybe 55-57% discount? Not sooo tempting, as there's just so much to buy at the moment - HVPE was almost 45% 2 days ago; Tetragon; OCI after a pullback at a lower discount but for serious quality/track record; ICGT/PIN/APEO; Wendel (not sure about growth, plus depends on bureau veritas); ONT; STB; OSB whenever it head back down towards £4; Shipping companies; a string of cheap banks.
Posted at 30/1/2024 17:39 by bamboo2
IP Group plc (LSE: IPO) ("IP Group" or "the Group"), which invests in breakthrough science and innovation companies with the potential to create a better future for all, issues an unaudited year-end update ahead of its results for the 12 months to 31 December 2023 now that the Group's usual year-end process is sufficiently progressed.

The market environment for early-stage investing remained challenging in 2023 and, against this backdrop, we saw some further softening of valuations in the final quarter of 2023. As a result, the Directors currently expect NAV per share to be between 111 pence and 117 pence at the year end.

Within this context, many of the Group's leading portfolio companies made strong progress, with some significant inflection points expected in 2024.

The Group continues to appropriately manage its investment levels and remains in a strong financial position with gross cash and deposits of £227m at year-end.

IP Group expects to announce its 2023 results on Wednesday 13 March 2024 following the completion of our usual year end valuations process.



Notes

- The share price of Oxford Nanopore Technologies plc was approximately 208 pence at the end of 2023.
Posted at 27/4/2023 16:19 by bamboo2
I checked again this afternoon, looking back over several reports, and realised an error in my early maths. These are the actual figures, so Imperial are still holding just over 30m shares, and they are using the closing price on the last day of the reporting month.

Will correct the above post.

Jan 23 £18,808,814 31/01/23 share price £0.61 £18,808,814/.61 = 30,834,121.3115 sh
Oct 22 £18,207,055 31/10/22 share price £0.59 £18,207,055/.59 = 30,859,415.2542 sh
Jul 22 £26,616,246 31/07/22 share price £0.86 £26,616,246/.86 = 30,949,123.2558 sh
Posted at 10/3/2023 12:50 by brucie5
Yes, agreed, and whole market down today. My folio which carries considerable value/income bias currently down 2.3%, so IPO (3.1%) not an outlier by much. 55p hit, and I think 50p may indeed follow.

But question is, what then. Or, what level is so absurd that the equivalent of PE decides to correct the anomaly? I understand that PE is not likely; but some cherry picking of distressed asset prices?

Anyone recall Shell at £9 in late 2020? Why did we all buy? At some point pension funds need to consider where the growth is going to come from tomorrow, never mind the dividends today. On a ten year view, and assuming continued progress with just the ten top holdings, where is IPO share price?
Posted at 18/4/2022 09:37 by pugugly
PO & b2 - Agree your reasoning, especially re cash but still feel that unless the American love affair with tech recovers significantly IPO share price will not recover/ Very similar to recent chart pattern to SMT.

Also possibly many PI's still suffering from the lessons of Woodford Patient Capital.

OK I fully appreciate that IPO management far more competent that the Woodford crew but IPO could well get tarred with the same brush.
Ip share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock